Excelsior Sciences
Focus: Excelsior Sciences is a Series A-stage biotechnology company focused on small molecule drug discovery, headquartered in New York. The company is in early-stage development with no commercial products or clinical trials currently reported.
Profile data last refreshed 7h ago · AI intelligence enriched 2w ago
Funding Stage
SERIES A
Open Jobs
0
About Excelsior Sciences
AI assessmentNot HiringNo open roles listed right now. Follow Excelsior Sciences to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Excelsior Sciences's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
0/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Open Jobs (0)
No open positions listed yet.
Interview Prep Quick Facts
H-1B (2023): 1 approval
Visa Sponsorship
Sponsors Work Visas
Help build intelligence for Excelsior Sciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.